Midatech Pharma PLC Stock Nasdaq
Equities
US59564R1041
Biotechnology & Medical Research
Sales 2024 * | 26K 33.64K | Sales 2025 * | 13K 16.82K | Capitalization | 8.05M 10.42M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 310 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 620 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0.09% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 62 | 19-09-08 |
Dan Palmer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 44 | 21-07-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Parker
CHM | Chairman | 65 | 22-06-19 |
Sijmen de Vries
BRD | Director/Board Member | 65 | 14-11-12 |
Stephen Stamp
CEO | Chief Executive Officer | 62 | 19-09-08 |
1st Jan change | Capi. | |
---|---|---|
+20.95% | 127B | |
+23.00% | 117B | |
+26.17% | 27.77B | |
-19.75% | 20.44B | |
-14.99% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |